USD 3.1 billion
Report ID:
SQMIG35A2376 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
90
|Figures:
76
Heart Pump Device Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 18.56 billion by 2032, growing at a CAGR of 22.0% during the forecast period (2025-2032).
The global heart pump device market is experiencing significant growth globally. Our report contains detailed information on the value chain analysis for the Heart Pump Device market, which manufacturers can use to gain a competitive edge during the projected period. The primary driving factor for this market growth is the increasing prevalence of cardiovascular diseases worldwide.
With the rising incidence of heart failure, the demand for heart pump devices has surged as they play a critical role in supporting and maintaining heart function in patients with severe cardiac conditions. Moreover, the growing aging population, which is more prone to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward.
Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have significantly improved patient outcomes and have increased their adoption. The development of magnetically levitated ventricular assist devices (VADs), for instance, has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications.
The heart pump device market is the increasing adoption of mechanical circulatory support devices. As the prevalence of advanced heart failure cases continues to rise, the need for long-term mechanical support has become crucial. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients waiting for heart transplantation or those who are not suitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patients ineligible for transplant, has further expanded the market's reach.
US Heart Pump Device Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 3.1 billion
Largest Segment
Ventricular Assist Devices (VADs)
Fastest Growth
Intra-Aortic Balloon Pumps (IABPs)
Growth Rate
22.0% CAGR
To get more reports on the above market click here to Buy The Report
Global Heart Pump Device Market is segmented by Product, Type, Therapy and region. Based on Product, the market is segmented into Ventricular Assist Devices, Intra-Aortic Balloon Pumps and Total Artificial Hearts. Based on Type, the market is segmented into Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices. Based on Therapy, the market is segmented into Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT) and Other Therapies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Ventricular Assist Devices (VADs) hold the largest share in the heart pump device market. VADs are further categorized into left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs) based on the ventricle they support. LVADs account for a significant portion of the VAD market due to their effectiveness in improving blood flow and prolonging survival in patients with end-stage heart failure. These devices are commonly used for both Bridge-to-Transplant (BTT) and Destination Therapy (DT) indications. The increasing adoption of LVADs in heart failure management has contributed to the dominance of the VAD segment in the market.
Intra-aortic balloon pumps (IABPs) represent the fastest growing segment in the heart pump device market. These devices provide temporary circulatory support by increasing coronary artery perfusion and reducing the workload of the heart. IABPs are widely used in high-risk procedures, such as cardiac surgeries and percutaneous coronary interventions (PCIs), as well as in patients with acute myocardial infarction and cardiogenic shock. These devices offer effective circulatory support during critical interventions, aiding in the stabilization of patients. Secondly, the demand for minimally invasive devices has surged, and IABPs fit this requirement as they can be inserted percutaneously.
Destination Therapy (DT) is the largest segment in the heart pump device market by indication. DT involves the long-term use of heart pump devices as a permanent solution for patients who are not eligible for heart transplantation. This indication is primarily targeted at patients with end-stage heart failure who are not expected to recover heart function or receive a heart transplant. The DT segment has gained prominence due to several factors. The increasing prevalence of heart failure and the growing aging population contribute to the rising demand for long-term mechanical circulatory support.
The fastest-growing segment in the heart pump device market by indication is Bridge-to-Recovery (BTR). BTR refers to the temporary use of heart pump devices to support patients with acute heart failure, with the goal of allowing the heart to recover its normal function. This indication is gaining significant traction due to various factors. The growing recognition of the potential for cardiac recovery in certain patients has driven the demand for BTR. Heart pump devices provide mechanical support to the failing heart, allowing it to rest and heal, which may lead to a complete recovery and the removal of the device
To get detailed analysis on other segments, Request For Free Sample Report
North America holds the largest share in the heart pump device market. This can be attributed to several factors. Firstly, the region has a high prevalence of cardiovascular diseases, including heart failure, which drives the demand for heart pump devices. Additionally, North America has a well-established healthcare infrastructure and a high level of awareness about advanced medical technologies, contributing to the adoption of heart pump devices. The presence of key market players and ongoing research and development activities further support the growth of the market in this region.
On the other hand, the Asia Pacific region is the fastest-growing region in the heart pump device market. The market in this region is experiencing significant growth due to various factors. Firstly, there is a rising prevalence of cardiovascular diseases, primarily driven by lifestyle changes, an aging population, and an increase in risk factors such as obesity and diabetes. This has led to an increased demand for heart pump devices. Secondly, improving healthcare infrastructure and rising healthcare expenditure in countries like China, India, and Japan are facilitating the adoption of advanced medical technologies, including heart pump devices.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Technological advancements
High Cost and Limited Reimbursement
Request Free Customization of this report to help us to meet your business objectives.
The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong global presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The Heart Pump Device market is poised for significant growth in the coming years, driven by various factors and offering substantial future scope. The heart pump device market is poised for significant growth in the coming years, driven by factors such as the increasing prevalence of heart failure, technological advancements, and the growing adoption of minimally invasive and implantable devices. The largest segment in the market is Destination Therapy (DT), offering long-term mechanical circulatory support for patients ineligible for heart transplantation. On the other hand, the fastest-growing segment is Bridge-to-Recovery (BTR), which provides temporary support for patients with acute heart failure, aiming to facilitate cardiac recovery. In terms of regional dominance, North America holds the largest market share due to a high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and favorable reimbursement policies. Looking ahead, the future scope of the heart pump device market is promising, with ongoing advancements in technology, increasing research activities, and collaborations driving innovation. Furthermore, the growing demand for minimally invasive and implantable devices, along with expanding market opportunities in the Asia Pacific region, are expected to fuel market growth. As the heart pump device market continues to evolve, companies will focus on product development, strategic partnerships, and expanding their global footprint to capitalize on the growing demand and provide advanced solutions for patients with heart failure.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 3.1 billion |
Market size value in 2032 | USD 18.56 billion |
Growth Rate | 22.0% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Heart Pump Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Heart Pump Device Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Heart Pump Device Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Heart Pump Device Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Heart Pump Device Market size was valued at USD 2.61 Billion in 2023 and is poised to grow from USD 3.26 Billion in 2024 to USD 19.11 Billion by 2032, growing at a CAGR of 24.77% during the forecast period (2025-2032).
The heart pump device market is highly competitive, with several key players vying for market share. The competitive landscape is characterized by intense rivalry, continuous technological advancements, strategic collaborations, and product innovations. Some of the prominent players in the market. These companies have a strong global presence and offer a wide range of heart pump devices catering to different indications and patient needs. Additionally, strategic partnerships, acquisitions, and collaborations with other companies and healthcare institutions are common strategies employed by key players to expand their market presence and gain a competitive edge. 'Abbott Laboratories (US)', 'Medtronic PLC (Ireland)', 'LivaNova PLC (United Kingdom)', 'Berlin Heart GmbH (Germany)', 'SynCardia Systems, LLC (US)', 'Abiomed, Inc. (US)', 'Getinge AB (Sweden)', 'Terumo Corporation (Japan)', 'Teleflex Incorporated (US)', 'Jarvik Heart, Inc. (US)', 'Fresenius Medical Care AG & Co. KGaA (Germany)', 'Calon Cardio (United Kingdom)', 'CardiacAssist, Inc. (US)', 'BiVACOR Inc. (Australia)', 'Leviticus Cardio Ltd. (Israel)', 'CARMAT SA (France)', 'FineHeart SA (France)', 'MyLVAD (US)', 'MicroPort Scientific Corporation (China)', 'TandemLife, a LivaNova company (US)'
Continuous innovation and advancements in heart pump technology have significantly improved the performance and outcomes of these devices. Technological advancements have led to the development of smaller, more durable, and more efficient heart pump devices, resulting in enhanced patient comfort and improved quality of life. For example, the introduction of magnetically levitated ventricular assist devices (LVADs) has reduced device-related complications and improved patient outcomes.
Availability of compatible devices: Compatible devices are designed to work harmoniously with heart pump systems, optimizing their performance and ensuring efficient functioning. For example, advanced control units can provide precise management of pump flow and parameters, enhancing patient outcomes. Similarly, compatible power sources can offer extended battery life and reliable power supply, minimizing device-related interruptions. These compatible devices often come with advanced monitoring and data management capabilities. It enables real-time remote monitoring, allowing healthcare professionals to track patient status and more.
North America holds the largest share in the heart pump device market. This can be attributed to several factors. Firstly, the region has a high prevalence of cardiovascular diseases, including heart failure, which drives the demand for heart pump devices. Additionally, North America has a well-established healthcare infrastructure and a high level of awareness about advanced medical technologies, contributing to the adoption of heart pump devices. The presence of key market players and ongoing research and development activities further support the growth of the market in this region.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2376
[email protected]
USA +1 351-333-4748